Schlumberger Investing Cash Flow increased by 102.6% to $33.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 107.6%, from -$432.00M to $33.00M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows a downward trend with a 50.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.00M | -$619.00M | -$526.00M | -$115.00M | $0.00 | -$1.08B | -$272.00M | -$547.00M | -$983.00M | -$733.00M | -$520.00M | -$151.00M | -$1.49B | -$1.02B | -$477.00M | -$432.00M | -$1.27B | $33.00M |
| QoQ Change | — | <-999% | +15.0% | +78.1% | +100.0% | — | +74.9% | -101.1% | -79.7% | +25.4% | +29.1% | +71.0% | -888.7% | +31.4% | +53.4% | +9.4% | -194.0% | +102.6% |
| YoY Change | — | — | — | — | -100.0% | -75.0% | +48.3% | -375.7% | — | +32.3% | -91.2% | +72.4% | -51.9% | -39.7% | +8.3% | -186.1% | -166.2% | +107.6% |